Expert Analysis

Expert Analysis: Colorectal Cancer

Source: CCO Independent Conference Coverage of the 2009 American Society of Clinical Oncology Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Expert Analysis: Colorectal Cancer

Faculty:

Edward Chu, MD
Richard M. Goldberg, MD
Alan P. Venook, MD

Moderator: Anthony El-Khoueiry, MD

CREDIT INFORMATION

Release Date: July 30, 2009

Expiration Date: July 29, 2010

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.3 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Analyze data from recent studies regarding current standards of care for colorectal cancer
Evaluate new data on novel agents and therapeutic approaches for colorectal cancer
Integrate new agents and treatment strategies into the clinical management of patients with colorectal cancer
Evaluate the role of molecular biomarkers in the treatment of patients with colorectal cancer

Topics covered include:

Gene Expression Assay for Predicting Recurrence in Stage II Colon Cancer
Prognostic Biomarkers in CRC
C-08: Addition of Bevacizumab to Chemotherapy in Stage II/III Colon Cancer
ACCENT: 2-Year DFS as a Surrogate Endpoint for OS in Stage III Colon Cancer
ACCENT: Impact of Older Age on Efficacy of Adjuvant Therapy
Addition of Oxaliplatin to Standard Preoperative Chemoradiotherapy in Rectal Cancer
KRAS, Other Molecular Predictors of EGFR-Targeted Therapy in Advanced CRC
KRAS Status and Responses to Panitumumab and FOLFIRI
Intravenous CaMg and Picoplatin for Reducing Treatment-Related Sensory Neuropathy
Conclusions

Abstract

Click here to view abstract

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.